89bio, Inc. (ETNB) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	8-K	8-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues	0.0	22.3	19.1	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	28.5	25.4	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	-6.2	-6.3	0.0	0.0	0.0	0.0	0.0
Gross margin		-27.9%	-33.0%
Selling, general and administrative [+]	42.1	6.2	6.3	4.8	24.7	5.3	5.3	4.6
General and administrative		6.2	6.3	4.8		5.3	5.3	4.6
Research and development				22.2		19.8	21.0	23.6
Other operating expenses	-42.1	-41.0	-38.0		-24.7
EBITDA [+]				-27.0	0.0	-25.1	-26.2	-28.2
EBITDA growth	-100.0%	-213.7%	-196.7%	-4.1%	-99.9%	70.4%	109.2%	95.6%
EBITDA margin		127.9%	133.0%
Depreciation and amortization				0.0	0.0	0.0	0.0	0.0
EBIT [+]	0.0	28.5	25.4	-27.0	0.0	-25.1	-26.2	-28.2
EBIT growth		-213.6%	-196.7%	-4.2%	-100.0%	70.4%	109.1%	95.5%
EBIT margin		127.9%	133.0%
Interest expense		2.1
Interest expense	0.9	2.1		0.5	0.4
Other income (expense), net	-37.5	2.4	-0.8	0.7	-24.6	-0.5	-0.2	-0.1
Pre-tax income	-38.4	28.8	24.6	-26.8	-25.1	-25.6	-26.4	-28.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	0.0
Tax rate	0.0%	0.0%			0.0%		0.6%	0.0%
Net income	-38.4	28.8	24.6	-26.8	-25.1	-25.6	-26.3	-28.3
Net margin		129.3%	129.0%

Basic EPS [+]	($0.52)	$0.54	$0.48	($0.57)	($1.23)	($1.26)	($1.31)	($1.41)
Growth	-57.9%	-143.1%	-137.0%	-59.8%	19.2%	70.1%	67.3%	63.0%
Diluted EPS [+]	($0.52)	$0.54	$0.48	($0.57)	($1.23)	($1.26)	($1.31)	($1.41)
Growth	-57.9%	-143.1%	-137.0%	-59.8%	19.2%	70.1%	67.3%	63.0%

Shares outstanding (basic) [+]	74.1	53.2	50.8	47.3	20.4	20.3	20.1	20.1
Growth	264.2%	161.4%	152.8%	135.2%	1.5%	1.6%	24.9%	19.0%
Shares outstanding (diluted) [+]	74.1	53.2	50.8	47.3	20.4	20.3	20.1	20.1
Growth	264.2%	161.4%	152.8%	135.2%	1.5%	1.6%	24.9%	19.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.